Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 99,004

Document Document Title
WO/2017/038601A1
The present invention addresses the problem of providing a meat which has a low saturated fatty acid content. It has been discovered that, as a result of feeding livestock animals a feed including Lactobacillus plantarum BB-PLT (lactic a...  
WO/2017/040801A3
The present invention relates to immunoconjugates having a ligand that binds to EpCAM and a toxin, and methods for making such immunoconjugates. Also encompassed by the invention are compositions and methods for the prevention or treatme...  
WO/2017/039001A1
Provided are a microorganism that is useful as an expression host for γ-Glu-Val synthase and a method for producing γ-Glu-Val-Gly using γ-Glu-Val synthase that is expressed in the microorganism. Starting with Glu, Val and Gly, γ-Glu-...  
WO/2017/036740A1
The present invention provides a recombinant cell genetically engineered to produce an increased amount of 5-aminovalerate compared to its wildtype. The invention further relates to a method for preparing 5-aminovalerate, the method comp...  
WO/2017/040378A1
2-ketoacid decarboxylase enzymes, compositions encoding for 2 ketoacid decarboxylase enzymes, and host cells comprising such enzymes or compositions are provided  
WO/2017/036903A1
The present invention provides an improved biotechnological production of riboflavin (also referred herein as vitamin B2) using genetically engineered microorganisms, in particular microorganism selected from Bacillus, such as e.g. Bacil...  
WO/2017/037629A1
Provided are improved microorganisms for the biosynthesis of pamamycins. Also provided are methods for the production of pamamycins using these microorganisms.  
WO/2017/037692A1
The present invention provides a process for production of fucoxanthin and/or polysaccharides from microalgae and the use of purified fucoxanthin thereof in pharmaceutical, cosmetic, nutraceutical and food compositions.  
WO/2017/035856A1
A Wautersiella enshiensis YLX-1 strain and application thereof, wherein the strain is deposited in China Center for Type Culture Collection (Wuhan) with the accession number being CCTCC No: M 2013671. The strain has the characteristics o...  
WO/2017/040719A1
The present invention provides recombinant bacterial cells comprising at least one heterologous gene encoding at least one oxalate catabolism enzyme. In another aspect, the recombinant bacterial cells further comprise at least one hetero...  
WO/2017/038993A1
The objective of the present invention is to provide a eukaryotic microalga which has been genetically manipulated so that more of the anabolites produced by photosynthesis are directed into triglyceride (triacylglycerol, TAG) synthesis....  
WO/2017/037241A1
The present application relates to the field of yeast, and specifically to the identification of yeast alleles that are involved in maximal alcohol accumulation and/or in tolerance to high alcohol levels. Preferably, said alcohol is etha...  
WO/2017/039361A1
The present invention relates to a Bacillus amyloliquefaciens CJ14-6 strain which is a strain isolated from traditional meju, a soybean koji preparation method using the same, and soybean koji prepared by the preparation method. The soyb...  
WO/2017/036294A1
Disclosed are Kluyveromyces marxianus, especially a type of Kluyveromyces marxianus with a deposit number of CGMCC No.10621; a use of the Kluyveromyces marxianus, the use comprising constructing a recombinant protein expression system an...  
WO/2017/036140A1
An A-group Neisseria meningitidis cultivation method comprises the following steps: (1) preparing purified strains of a working seed lot; (2) opening the strains of the working seed lot, inoculating same into a semi-synthetic culture med...  
WO/2017/039106A1
The present invention relates to a novel strain Methylomonas sp. DH-1 and a use thereof and, more specifically, to a strain Methylomonas sp. DH-1, deposited as Accession Number KCTC13004BP, synthesizing methanol from methane, to a compos...  
WO/2017/040273A2
Compositions and methods for treating or preventing plant disease are provided. Such compositions and methods comprise a bacterial strain that control one or more pathogens that cause plant disease or improve at least one agronomic trait...  
WO/2017/033464A1
A method for producing an objective substance such as phytosphingosine and sphinganine using yeast is provided. An objective substance is produced by cultivating yeast having an ability to produce the objective substance and modified so ...  
WO/2017/035270A1
Provided herein are recombinant host cells having an active 3-Hydroxypropionic Acid (3-HP) pathway wherein the host cells comprise a heterologous polynucleotide encoding an aminotransferase of E.C. 2.6.1.19 and wherein the aminotransfera...  
WO/2017/034388A2
Present invention discloses a method of production of Lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/034984A1
The presently disclosed subject matter provides methods for inhibiting the growth and/or survival of bacteria from the Borrelia genus and for treating Lyme disease. These methods include agents that inhibit the glutathione/γ-glutamyl pa...  
WO/2017/033652A1
The present invention addresses the problem of providing a novel short-chain polyhydroxyalkanoate (PHA) having free hydroxy groups and a method for producing the same. Provided are a PHA that comprises, each as a monomer unit, a dihydrox...  
WO/2017/031838A1
Disclosed is a method for producing L-ornithine by whole-cell biotransformation using recombinant Bacillus subtilis, wherein the method comprises constructing Bacillus subtilis 168 engineering bacteria which express arginase originated f...  
WO/2017/031985A1
Provided is an application of Butyribacterintestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.  
WO/2017/034388A3
Present invention discloses a method of production of Lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/034011A1
The present invention pertains to a proliferation agent for increasing, or causing the proliferation of, beneficial intestinal bacteria (primarily, bifidobacteria and/or lactobacilli), the proliferation agent being characterized by conta...  
WO/2017/034388A8
Present invention discloses a method of production of lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/035191A1
The present invention is a method of enriching at least one bacterial species from a target bacterial system, including: culturing the target bacterial ecosystem in a culture media in a single-stage chemostat under the following conditio...  
WO/2017/033925A1
Provided is a novel butyric acid-producing bacterium that belongs to the Clostridium leptum subgroup, and, in a butyric acid-free culture medium, produces butyric acid but does not produce formic acid.  
WO/2017/034387A3
The embodiments of the present invention relate to a method of producing lignocellulolytic enzymes using a species of white rot fungi by solid stale fermentation (SSF) is provided. The method comprises obtaining artificially modified fun...  
WO/2017/034387A2
The embodiments of the present invention relate to a method of producing lignocellulolytic enzymes using a species of white rot fungi by solid stale fermentation (SSF) is provided. The method comprises obtaining artificially modified fun...  
WO/2017/034827A1
A method for increasing the concentration of metal carbonates in a heavy metal contaminated geomaterial utilizing indigenous ureolytic microorganisms. The method may be used for bioremediation of heavy metal contaminated geomaterials.  
WO/2017/032909A1
Disclosed are mutant strains of Staphylococcus aureus with multiple inactivated TCS systems. The invention relates to mutant strains of S. aureus deprived of all non-essential two-component signal systems (TCSs) and even the essential Wa...  
WO/2017/034460A1
The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting...  
WO/2017/031839A1
Provided are an L-asparaginase mutant with improved enzyme activity and a construction method thereof, wherein the mutant is constructed on the basis of the amino acid sequence as shown in the SEQ ID NO.2, in which glycine at position 10...  
WO/2017/035101A1
The present specification discloses plant agent compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a causal agent of a plant disease or increasing plant growth and/or f...  
WO/2017/035188A1
The present invention provides a method, wherein the method treats a subject having a dysbiosis, the method comprising: determining a first metabolic profile of the gut microbiome of a subject having a dysbiosis; changing the first metab...  
WO/2017/035141A3
The present invention provides microorganisms capable of converting acetyl-coA into crotyl alcohol as well as fermentation methods for producing crotyl alcohol, either alone, or in combination with acetone and/or isopropanol. The microor...  
WO/2017/034942A1
The present invention relates to the production of chemical species in bacterial host cells. Particularly, the present invention provides for the production of chemical species in Escherichia coli (E. coli) host cells that functionally e...  
WO/2017/034699A1
The present invention is directed to a method and kit for inactivation of acid -fast bacteria. In some embodiments, the method may include: transferring a sample from a liquid culture containing acid-fast bacteria to a first tube, wherei...  
WO/2017/033188A1
Methods of producing algal oil and algal biofuel are provided. Accordingly there is provided a method of producing oil, the method comprising infecting Emiliania huxleyi microalgae with a Coccolithovirus Eh V201; and extracting the oil f...  
WO/2017/032739A1
The present invention relates to methods and pharmaceutical compositions for preventing or treating inflammatory bowel diseases.  
WO/2017/033965A1
Provided is a method for producing an aromatic compound, e.g., salicylic acid, and a derivative thereof with high productivity using a microorganism. Provided are: a method for producing a microorganism having a modified sugar metabolic ...  
WO/2017/029833A1
Provided is a method for site-specific insertion of a foreign DNA into an animal cell genome, said method comprising: (1) a step for constructing a donor plasmid in which 100-300 bp DNAs having a sequence homologous to an insertion site ...  
WO/2017/030503A1
The present invention relates to the field of fermentation biotechnology, more particularly to methods for the fermentative production of massoia lactone by Aureobasidium species.  
WO/2017/031277A1
Provided herein are methods for identifying and obtaining environmental isolates of microorganisms that maintain viability following seed treatment components or seed treatment processes and storage.  
WO/2017/030172A1
A neutral monoclonal antibody useful for effective antibody therapy against Ebola virus is needed. The present invention provides a monoclonal antibody or antigen-binding fragment thereof that is capable of recognizing the GP internal me...  
WO/2017/028040A1
The present invention provides a mycobacterium tuberculosis antigen for differentiating active tuberculosis with latent tuberculosis infection and applications thereof. Specifically, the present invention provides an immunogenic composit...  
WO/2017/030156A1
The present invention pertains to: a monoclonal antibody or a fragment thereof that includes at least one lysine derivative in the constant region of the human IgG antibody; a modified antibody or a fragment thereof in which the lysine d...  
WO/2017/029823A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, a filter is used to separate a biological culture solution including micro-nanobubbles into a filtrate and a concentrate o...  

Matches 551 - 600 out of 99,004